1. Home
  2. ECOR vs FMY Comparison

ECOR vs FMY Comparison

Compare ECOR & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • FMY
  • Stock Information
  • Founded
  • ECOR 2005
  • FMY 2005
  • Country
  • ECOR United States
  • FMY United States
  • Employees
  • ECOR N/A
  • FMY N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FMY Finance/Investors Services
  • Sector
  • ECOR Health Care
  • FMY Finance
  • Exchange
  • ECOR Nasdaq
  • FMY Nasdaq
  • Market Cap
  • ECOR 40.1M
  • FMY 49.6M
  • IPO Year
  • ECOR 2018
  • FMY N/A
  • Fundamental
  • Price
  • ECOR $5.19
  • FMY $12.11
  • Analyst Decision
  • ECOR Strong Buy
  • FMY
  • Analyst Count
  • ECOR 2
  • FMY 0
  • Target Price
  • ECOR $25.50
  • FMY N/A
  • AVG Volume (30 Days)
  • ECOR 122.7K
  • FMY 10.1K
  • Earning Date
  • ECOR 05-07-2025
  • FMY 01-01-0001
  • Dividend Yield
  • ECOR N/A
  • FMY 6.98%
  • EPS Growth
  • ECOR N/A
  • FMY N/A
  • EPS
  • ECOR N/A
  • FMY N/A
  • Revenue
  • ECOR $25,182,000.00
  • FMY N/A
  • Revenue This Year
  • ECOR $32.20
  • FMY N/A
  • Revenue Next Year
  • ECOR $46.27
  • FMY N/A
  • P/E Ratio
  • ECOR N/A
  • FMY N/A
  • Revenue Growth
  • ECOR 57.09
  • FMY N/A
  • 52 Week Low
  • ECOR $5.02
  • FMY $10.71
  • 52 Week High
  • ECOR $19.49
  • FMY $12.17
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 31.29
  • FMY 54.68
  • Support Level
  • ECOR $6.01
  • FMY $11.95
  • Resistance Level
  • ECOR $7.14
  • FMY $12.24
  • Average True Range (ATR)
  • ECOR 0.80
  • FMY 0.13
  • MACD
  • ECOR 0.07
  • FMY 0.01
  • Stochastic Oscillator
  • ECOR 3.99
  • FMY 66.26

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

Share on Social Networks: